KNTE

Kinnate Biopharma Inc. Common Stock
KNTE

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

KNTE was delisted on the 2nd of April, 2024.

Back to rankings

55 hedge funds and large institutions have $1.43B invested in Kinnate Biopharma Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 55 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
55
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$385M
2
+$153M
3
+$143M
4
VVA
Vida Ventures Advisors
Massachusetts
+$109M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$94.1M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6.66M
27
$4.97M
28
$4.25M
29
$3.57M
30
$2.71M
31
$2.4M
32
$1.61M
33
$1.59M
34
$1.52M
35
$1.17M
36
$1.02M
37
$995K
38
$995K
39
$835K
40
$607K
41
$597K
42
$533K
43
$533K
44
$412K
45
$284K
46
$242K
47
$241K
48
$237K
49
$227K
50
$223K
1
2
3